Showing results (201-210 of 222) with videos related to
Sort By:
Pageof 23
Journal of Affective Disorders|December 24, 2021
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment responseMaya Kuperberg, Ole Köhler-Forsberg, Alec P Shannon, et al.Journal of Affective Disorders|May 19, 2020
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment responseOle Köhler-Forsberg, Louisa G Sylvia, Valerie L Ruberto, et al.Acta Psychiatrica Scandinavica|March 4, 2022
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorderAnna L Wrobel, Ole Köhler-Forsberg, Louisa G Sylvia, et al.Journal of Psychiatry and Brain Science|August 29, 2020
Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †Natalie de la Garrigue, Juliana Glasser, Pejman Sehatpour, et al.International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.The American Journal of Psychiatry|March 3, 2021
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled TrialSara Costi, Laurel S Morris, Katherine A Kirkwood, et al.The American Journal of Psychiatry|March 17, 2021
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and ImplementationRoger S McIntyre, Joshua D Rosenblat, Charles B Nemeroff, et al.International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.Sleep|December 16, 2025
High OSA hypoxic burden associates with reduced locus coeruleus structural integrity on 7T MRI in older adultsKorey Kam, Naomi L Gaggi, Ankit Parekh, et al.Pageof 23